CN102911169B - Method for preparing lurasidone - Google Patents
Method for preparing lurasidone Download PDFInfo
- Publication number
- CN102911169B CN102911169B CN201110220005.1A CN201110220005A CN102911169B CN 102911169 B CN102911169 B CN 102911169B CN 201110220005 A CN201110220005 A CN 201110220005A CN 102911169 B CN102911169 B CN 102911169B
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- reaction
- hours
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PQXKDMSYBGKCJA-CVTJIBDQSA-N O=C([C@H]1[C@@H]2[C@H]3C[C@@H]1CC3)N(C[C@H]1[C@H](CN(CC3)CCN3c3n[s]c4ccccc34)CCCC1)C2=O Chemical compound O=C([C@H]1[C@@H]2[C@H]3C[C@@H]1CC3)N(C[C@H]1[C@H](CN(CC3)CCN3c3n[s]c4ccccc34)CCCC1)C2=O PQXKDMSYBGKCJA-CVTJIBDQSA-N 0.000 description 1
- RIVOBMOBWMOLDJ-RNGGSSJXSA-N O=C([C@H]1[C@@H]2[C@H]3C[C@@H]1CC3)NC2=O Chemical compound O=C([C@H]1[C@@H]2[C@H]3C[C@@H]1CC3)NC2=O RIVOBMOBWMOLDJ-RNGGSSJXSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种如式I所示的卢拉西酮的制备方法,其包括下列步骤:在极性非质子溶剂中,在碱的作用下,将化合物II或化合物III,与化合物IV在50~150℃下进行如下反应,即可;本发明的卢拉西酮的制备方法收率高、操作简便、成本低,适合于工业上大规模生产,为卢拉西酮的制备提供了一条新的途径。 The invention discloses a preparation method of lurasidone as shown in formula I, which comprises the following steps: in a polar aprotic solvent, under the action of a base, compound II or compound III, and compound IV in The following reactions can be carried out at 50-150°C; the preparation method of lurasidone of the present invention has high yield, simple operation and low cost, is suitable for large-scale industrial production, and provides a new method for the preparation of lurasidone new way.
Description
技术领域 technical field
本发明涉及一种卢拉西酮的制备方法。The invention relates to a preparation method of lurasidone.
背景技术 Background technique
精神病是一种常见疾病,发病率约占人口总数的百分之一。随着生活节奏的加快、社会交往的频繁,精神病日益成为多发疾病,尤其是在人口相对集中的城市。目前,抗精神病药物在全球市场的年销售额高达162亿美元,成为降胆固醇类药物之后的第五大治疗类别。Mental illness is a common disease, affecting about one percent of the population. With the accelerated pace of life and frequent social interactions, mental illness has increasingly become a frequent disease, especially in cities with a relatively concentrated population. At present, antipsychotic drugs have annual sales of 16.2 billion US dollars in the global market, making them the fifth largest therapeutic category after cholesterol-lowering drugs.
现有的抗精神分裂药物中,氟哌啶醇、奥氮平等药物容易引起体重增加,且锥体外系不良反应严重;甲磺酸齐拉西酮控制精神分裂症的急性激越症状疗效明显,且无体重增加的不良反应,但是仍有心脏QT间歇延长的不良反应。Among the existing antipsychotic drugs, haloperidol, olanzapine and other drugs are likely to cause weight gain, and the extrapyramidal adverse reactions are serious; ziprasidone mesylate is effective in controlling the acute agitation symptoms of schizophrenia, and There were no adverse reactions of weight gain, but there were adverse reactions of cardiac QT prolongation.
2010年上市的抗精神分裂新药盐酸卢拉西酮,化学名为(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-苯并异噻唑-3-基)哌嗪-1-基]甲基]环己基甲基}六氢-4,7-亚甲基-2H-异吲哚-1,3-二酮盐酸盐,其结构式如下:Lurasidone hydrochloride, a new anti-schizophrenic drug launched in 2010, has a chemical name of (3aR, 4S, 7R, 7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazole -3-yl)piperazin-1-yl]methyl]cyclohexylmethyl}hexahydro-4,7-methylene-2H-isoindole-1,3-dione hydrochloride, its structural formula is as follows :
其主要特点在于起效更快,血药达峰时间为1~3小时,对心脏QTc间歇影响小,且半衰期长达18小时,可以更好地控制精神分裂症(参见http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/200603Orig1s000SumR.pdf)。Its main features are faster onset of action, peak blood drug time of 1 to 3 hours, less intermittent impact on cardiac QTc, and a half-life of up to 18 hours, which can better control schizophrenia (see http://www. accessdata.fda.gov/drugsatfda_docs/nda/2010/200603Orig1s000SumR.pdf).
卢拉西酮,即光学活性的(1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基甲基]-2,3-二环[2.2.1]庚烷-二甲酰亚胺(化合物I)是用于治疗精神分裂症的盐酸卢拉西酮的游离碱形式。Lurasidone, the optically active (1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1- Piperazinylmethyl]-2,3-bicyclo[2.2.1]heptane-dicarboximide (Compound I) is the free base form of lurasidone hydrochloride used in the treatment of schizophrenia.
EP0464846报道了化合物I的制备方法,在碳酸钾的存在下,将化合物II与化合物IV在二甲苯中回流16小时,即可,但未报道该反应的收率。该方法需要加入相转移催化剂二苯-18-冠-6-醚,成本较高,反应时间也较长,而且需要进行柱层析分离才能得到纯品。EP0464846 reports the preparation method of compound I. In the presence of potassium carbonate, compound II and compound IV are refluxed in xylene for 16 hours, but the yield of the reaction is not reported. This method needs to add phase transfer catalyst diphenyl-18-crown-6-ether, the cost is high, the reaction time is also long, and the pure product needs to be separated by column chromatography.
JP2006169155也报道了化合物I的制备方法,在细颗粒状(比表面积0.6m2/g)碳酸钾的存在下,将化合物II与化合物IV在甲苯中回流2小时,收率89.5%。JP2006169154报道,在JP2006169155所述制备方法中,加入相转移催化剂有助于提高反应收率至93.9%。本发明人经过实践发现,上述反应为非均相反应,化合物II在甲苯中不溶解,因此,在实际操作过程中,化合物II不能完全反应,实际收率低于65%;而且当溶剂量超过1L时,反应过程中,化合物II和碳酸钾易结块,导致反应率进一步降低至30~40%。JP2006169155 also reported the preparation method of compound I. In the presence of fine granular (specific surface area 0.6m 2 /g) potassium carbonate, compound II and compound IV were refluxed in toluene for 2 hours, and the yield was 89.5%. JP2006169154 reports that in the preparation method described in JP2006169155, adding a phase transfer catalyst helps to increase the reaction yield to 93.9%. The inventor finds through practice that the above-mentioned reaction is a heterogeneous reaction, and compound II is insoluble in toluene. Therefore, in the actual operation process, compound II cannot completely react, and the actual yield is lower than 65%; and when the amount of solvent exceeds At 1 L, during the reaction, compound II and potassium carbonate tend to agglomerate, resulting in a further reduction in the reaction rate to 30-40%.
发明内容 Contents of the invention
本发明所要解决的技术问题是克服了现有的卢拉西酮的制备方法中存在的反应时间长、反应不完全、制备成本高、后处理过程复杂,不适合工业上大规模制备的缺陷,而提供了一种卢拉西酮的制备方法。该方法收率高、操作简便、成本低,适合于工业上大规模生产。The technical problem to be solved by the present invention is to overcome the defects of long reaction time, incomplete reaction, high preparation cost, complicated post-treatment process and unsuitability for industrial large-scale preparation in the existing preparation method of lurasidone. And a preparation method of lurasidone is provided. The method has the advantages of high yield, simple operation and low cost, and is suitable for industrial large-scale production.
因此,本发明涉及一种如式I所示的卢拉西酮的制备方法,其包括下列步骤:在极性非质子溶剂中,在碱的作用下,将化合物II或化合物III,与化合物IV在50~150℃下进行如下反应,即可;Therefore, the present invention relates to a preparation method of lurasidone as shown in formula I, which comprises the following steps: in a polar aprotic solvent, under the action of a base, compound II or compound III, and compound IV Carry out the following reaction at 50-150°C;
其中,所述的极性非质子溶剂较佳的为N,N-二甲基甲酰胺(DMF)、二甲基亚砜(DMSO)、N,N-二甲基乙酰胺(DMAC)、六甲基磷酰三胺(HMPA)和N,N-二甲基乙醇胺(DMEA)中的一种或多种;更佳的为N,N-二甲基甲酰胺(DMF)。所述的极性非质子溶剂的用量可为本领域此类反应的常规用量;较佳地,所述的极性非质子溶剂与化合物II或化合物III的体积质量比为3~100ml/g;更佳的为10~30ml/g;最佳的为10~20ml/g。所述的碱可为本领域此类反应的常规碱,如无机碱和/或有机碱。所述的无机碱较佳的为氢氧化钾、氢氧化钠、氢氧化锂、碳酸钾、碳酸钠和碳酸氢钠中的一种或多种;优选碳酸钾。所述的有机碱较佳的为吡啶和/或三级胺;所述的三级胺较佳的为三乙胺和/或二异丙基乙基胺。所述的碱的用量可为本领域此类反应的常规用量;较佳地,所述的碱与化合物II或化合物III的摩尔比为1∶5~1∶0.2;更佳的为1∶1~1∶0.5。所述的化合物IV的用量可为本领域此类反应的常规用量;较佳地,所述的化合物IV与化合物II或化合物III的摩尔比为1∶0.8~1∶2;更佳的为1∶1~1∶1.1。所述的反应的温度较佳的为100~150℃。所述的反应的时间较佳的以检测反应完成为止,一般为2~24小时,优选5~10小时。Wherein, the polar aprotic solvent is preferably N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), N,N-dimethylacetamide (DMAC), six One or more of methylphosphoric triamide (HMPA) and N,N-dimethylethanolamine (DMEA); more preferably N,N-dimethylformamide (DMF). The amount of the polar aprotic solvent can be the conventional amount used in this type of reaction in the art; preferably, the volume-mass ratio of the polar aprotic solvent to compound II or compound III is 3-100ml/g; More preferably 10-30ml/g; best 10-20ml/g. The base may be a conventional base for this type of reaction in the art, such as an inorganic base and/or an organic base. The inorganic base is preferably one or more of potassium hydroxide, sodium hydroxide, lithium hydroxide, potassium carbonate, sodium carbonate and sodium bicarbonate; preferably potassium carbonate. The organic base is preferably pyridine and/or tertiary amine; the tertiary amine is preferably triethylamine and/or diisopropylethylamine. The amount of the base can be the conventional amount of this type of reaction in the art; preferably, the molar ratio of the base to compound II or compound III is 1:5 to 1:0.2; more preferably 1:1 ~1:0.5. The amount of the compound IV can be the conventional amount of this type of reaction in the art; preferably, the molar ratio of the compound IV to the compound II or the compound III is 1:0.8~1:2; more preferably 1 : 1~1: 1.1. The temperature of the reaction is preferably 100-150°C. The reaction time is preferably until the completion of the detection reaction, generally 2-24 hours, preferably 5-10 hours.
本发明中,所述的化合物II和化合物III可参照EP464846中的方法,由市售的trans-环己二酸制得;所述的化合物IV可参照Bioorganic & MedicinalChemistry 12(2004)4565~4573和EP0261688中的方法,由市售的外-降冰片烯酸酐制得。In the present invention, the compound II and compound III can be prepared from commercially available trans-cycloadipic acid with reference to the method in EP464846; the compound IV can be obtained with reference to Bioorganic & Medicinal Chemistry 12 (2004) 4565-4573 and The method among EP0261688, is made from commercially available exo-norbornene anhydride.
本发明中所述的原料或试剂除特别说明之外,均市售可得。Unless otherwise specified, the raw materials or reagents described in the present invention are commercially available.
本发明的积极进步效果在于:本发明的卢拉西酮的制备方法收率高、操作简便、成本低,适合于工业上大规模生产,为卢拉西酮的制备提供了一条新的途径。The positive and progressive effects of the present invention are: the preparation method of lurasidone of the present invention has high yield, simple operation and low cost, is suitable for industrial large-scale production, and provides a new way for the preparation of lurasidone.
具体实施方式 Detailed ways
下面用实施例来进一步说明本发明,但本发明并不受其限制。The present invention is further illustrated below with examples, but the present invention is not limited thereto.
实施例中所用的原料或试剂除特别说明之外,均市售可得。Unless otherwise specified, the raw materials or reagents used in the examples are commercially available.
实施例中所述的化合物II和化合物III参照EP464846中的方法,由市售的trans-环己二酸制得;所述的化合物IV参照Bioorganic & MedicinalChemistry 12(2004)4565~4573和EP0261688中的方法,由市售的外-降冰片烯酸酐制得。Compound II and Compound III described in the examples were prepared from commercially available trans-cycloadipic acid with reference to the method in EP464846; described Compound IV was prepared with reference to Bioorganic & Medicinal Chemistry 12 (2004) 4565-4573 and EP0261688 Method, prepared from commercially available exo-norbornene anhydride.
对比实施例 按照JP2006169154中的方法制备化合物IComparative Example Compound I was prepared according to the method in JP2006169154
将30.0g化合物II和10.9g碳酸钾置于反应瓶中,加入560ml甲苯,搅拌,再加入11.9g化合物IV,加热至110℃,反应2小时,未反应完全。补加0.8g四正丁基硫酸氢铵,继续反应4小时。反应结束,加入320ml水,搅拌,固体全部溶解,过滤,除去少许絮状物,滤液分层,分液,水相用150ml甲苯洗涤,合并甲苯层,用水洗涤(150ml×2),再用150ml饱和氯化钠水溶液洗涤,无水硫酸钠干燥,过滤,除去干燥剂,减压浓缩,得浅黄色固体化合物I12.2g,收率35%。Put 30.0g of compound II and 10.9g of potassium carbonate in a reaction flask, add 560ml of toluene, stir, then add 11.9g of compound IV, heat to 110°C, and react for 2 hours, but the reaction is not complete. 0.8 g of tetra-n-butylammonium bisulfate was added, and the reaction was continued for 4 hours. After the reaction is over, add 320ml of water, stir, all the solids are dissolved, filter, remove a little floc, separate the layers of the filtrate, wash the aqueous phase with 150ml of toluene, combine the toluene layers, wash with water (150ml×2), and then wash with 150ml of toluene Wash with saturated aqueous sodium chloride, dry over anhydrous sodium sulfate, filter, remove the desiccant, and concentrate under reduced pressure to obtain 12.2 g of compound I as a pale yellow solid with a yield of 35%.
实施例1 制备化合物IExample 1 Preparation of Compound I
将5g(11.8mmol)化合物II、2.2g(13.3mmol)化合物IV和1.9g(13.7mmol)碳酸钾置于反应瓶中,加入100ml N,N-二甲基甲酰胺(DMF),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重5.25g,收率90%。5g (11.8mmol) compound II, 2.2g (13.3mmol) compound IV and 1.9g (13.7mmol) potassium carbonate were placed in the reaction flask, added 100ml N, N-dimethylformamide (DMF), heated to 130 °C, react for 4 hours. After the reaction, 100ml of water was added, stirred at room temperature for 2 hours, a large amount of solid was precipitated, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 5.25g after drying, with a yield of 90%.
其结构鉴定数据如下:Its structural identification data are as follows:
1H NMR(DMSO-d6)δ:ppm 1.1-1.2(3H,d),2.0-2.1(2H,m),2.5-2.6(1H,dd),2.8-2.9(2H,t),2.96-3.0(1H,dd),3.3-3.5(3H,m),3.5-3.7(4H,m),4.2-4.3(2H,t),4.3-4.4(2H,t),4.6-4.7(2H,m),4.8-5.2(1H,br),6.9-7.15(6H,m),7.3-7.4(2H,m),8.0-8.1(2H,m)。 1 H NMR (DMSO-d 6 ) δ: ppm 1.1-1.2 (3H, d), 2.0-2.1 (2H, m), 2.5-2.6 (1H, dd), 2.8-2.9 (2H, t), 2.96- 3.0(1H,dd), 3.3-3.5(3H,m), 3.5-3.7(4H,m), 4.2-4.3(2H,t), 4.3-4.4(2H,t), 4.6-4.7(2H,m ), 4.8-5.2 (1H, br), 6.9-7.15 (6H, m), 7.3-7.4 (2H, m), 8.0-8.1 (2H, m).
实施例2 制备化合物IEmbodiment 2 preparation compound I
将5g化合物II、2.2g化合物IV和1.9g碳酸钾置于反应瓶中,加入100mlN,N-二甲基甲酰胺(DMF),加热至50℃,反应24小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得白色固体,烘干后重3.4g,收率60%,其结构鉴定数据同实施例1。Put 5g of compound II, 2.2g of compound IV and 1.9g of potassium carbonate in a reaction flask, add 100ml of N,N-dimethylformamide (DMF), heat to 50°C, and react for 24 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 3.4g after drying, and the yield was 60%. The structural identification data was the same as in Example 1.
实施例3 制备化合物IExample 3 Preparation of Compound I
将5g化合物II、2.2g化合物IV和1.9g碳酸钾置于反应瓶中,加入100mlN,N-二甲基甲酰胺(DMF),加热至150℃,反应3小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重5.0g,收率86%,其结构鉴定数据同实施例1。Put 5g of compound II, 2.2g of compound IV and 1.9g of potassium carbonate in a reaction flask, add 100ml of N,N-dimethylformamide (DMF), heat to 150°C, and react for 3 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 5.0g after drying, with a yield of 86%, and its structural identification data was the same as in Example 1.
实施例4 制备化合物IExample 4 Preparation of Compound I
将3g化合物II、1.4g化合物IV和1.2g碳酸钾置于反应瓶中,加入100ml二甲基亚砜(DMSO),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重3.1g,收率88%,其结构鉴定数据同实施例1。Put 3g of compound II, 1.4g of compound IV and 1.2g of potassium carbonate in a reaction flask, add 100ml of dimethylsulfoxide (DMSO), heat to 130°C, and react for 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 3.1g after drying, with a yield of 88%, and its structural identification data was the same as in Example 1.
实施例5 制备化合物IExample 5 Preparation of Compound I
将1.0g化合物II、0.44g化合物IV和0.40g碳酸钾置于反应瓶中,加入20mlN,N-二甲基乙醇胺(DMEA),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重0.98g,收率85%,其结构鉴定数据同实施例1。Put 1.0g of compound II, 0.44g of compound IV and 0.40g of potassium carbonate in a reaction flask, add 20ml of N,N-dimethylethanolamine (DMEA), heat to 130°C, and react for 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 0.98g after drying, and the yield was 85%. The structural identification data was the same as in Example 1.
实施例6 制备化合物IExample 6 Preparation of Compound I
将1.0g化合物II、0.44g化合物IV和0.40g碳酸钾置于反应瓶中,加入20ml N,N-二甲基乙酰胺(DMAC),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重1.02g,收率88%,其结构鉴定数据同实施例1。Put 1.0g of compound II, 0.44g of compound IV and 0.40g of potassium carbonate in a reaction flask, add 20ml of N,N-dimethylacetamide (DMAC), heat to 130°C, and react for 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 1.02g after drying, with a yield of 88%, and its structural identification data was the same as in Example 1.
实施例7 制备化合物IExample 7 Preparation of Compound I
将5g化合物II、2.2g化合物IV和1.9g碳酸钾置于反应瓶中,加入100ml六甲基磷酰三胺(HMPA),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重5.2g,收率89%,其结构鉴定数据同实施例1。Put 5g of compound II, 2.2g of compound IV and 1.9g of potassium carbonate in a reaction flask, add 100ml of hexamethylphosphoric triamide (HMPA), heat to 130°C, and react for 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 5.2g after drying, and the yield was 89%. The structural identification data was the same as in Example 1.
实施例8 制备化合物IExample 8 Preparation of Compound I
将2.0g化合物II、0.88g化合物IV和0.56g三乙胺置于反应瓶中,加入40ml N,N-二甲基甲酰胺,加热至80℃,反应8小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重1.6g,收率70%,其结构鉴定数据同实施例1。Put 2.0g of compound II, 0.88g of compound IV and 0.56g of triethylamine in a reaction flask, add 40ml of N,N-dimethylformamide, heat to 80°C, and react for 8 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 1.6g after drying, with a yield of 70%. The structural identification data was the same as in Example 1.
实施例9 制备化合物IExample 9 Preparation of Compound I
将2g化合物II、0.88g化合物IV和0.56g二异丙基乙基胺置于反应瓶中,加入40ml N,N-二甲基甲酰胺,加热至110℃,反应6小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干1.7g,收率73%,其结构鉴定数据同实施例1。Put 2g of compound II, 0.88g of compound IV and 0.56g of diisopropylethylamine in a reaction flask, add 40ml of N,N-dimethylformamide, heat to 110°C, and react for 6 hours. After the reaction, add 100ml of water, stir at room temperature for 2 hours, precipitate a large amount of solid, filter, wash the filter cake with water to obtain a white solid, dry 1.7g, yield 73%, its structural identification data are the same as in Example 1.
实施例10 制备化合物IExample 10 Preparation of Compound I
将2.0g化合物II、0.88g化合物IV和0.24g氢氧化钠置于反应瓶中,加入40ml N,N-二甲基甲酰胺,加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重1.2g,收率52%,其结构鉴定数据同实施例1。Put 2.0g of compound II, 0.88g of compound IV and 0.24g of sodium hydroxide in a reaction flask, add 40ml of N,N-dimethylformamide, heat to 130°C, and react for 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 1.2g after drying, with a yield of 52%, and its structural identification data was the same as in Example 1.
实施例11 制备化合物IExample 11 Preparation of Compound I
将2g化合物II、0.88g化合物IV和0.32g氢氧化钾置于反应瓶中,加入40ml N,N-二甲基甲酰胺,加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重1.2g,收率52%,其结构鉴定数据同实施例1。Put 2g of compound II, 0.88g of compound IV and 0.32g of potassium hydroxide in a reaction flask, add 40ml of N,N-dimethylformamide, heat to 130°C, and react for 4 hours. After the reaction, add 100ml of water, stir at room temperature for 2 hours, separate out a large amount of solid, filter, wash the filter cake with water to obtain a white solid, weigh 1.2g after drying, yield 52%, its structural identification data is the same as in Example 1.
实施例12 制备化合物IExample 12 Preparation of Compound I
将2g化合物II、0.88g化合物IV和0.16g氢氧化锂置于反应瓶中,加入40ml N,N-二甲基甲酰胺,加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重1.3g,收率56%,其结构鉴定数据同实施例1。Put 2g of compound II, 0.88g of compound IV and 0.16g of lithium hydroxide in a reaction flask, add 40ml of N,N-dimethylformamide, heat to 130°C, and react for 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 1.3g after drying, and the yield was 56%.
实施例13 制备化合物IExample 13 Preparation of Compound I
将5g化合物II、2.2g化合物IV和1.5g碳酸钠置于反应瓶中,加入100mlN,N-二甲基甲酰胺,加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重4.9g,收率84%,其结构鉴定数据同实施例1。Put 5g of compound II, 2.2g of compound IV and 1.5g of sodium carbonate in a reaction flask, add 100ml of N,N-dimethylformamide, heat to 130°C, and react for 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 4.9g after drying, with a yield of 84%, and its structural identification data was the same as in Example 1.
实施例14 制备化合物IExample 14 Preparation of Compound I
将5g(11.8mmol)化合物II、14.7mmol化合物IV和2.36mmol氢氧化钾置于反应瓶中,加入15ml N,N-二甲基甲酰胺(DMF),加热至100℃,反应14小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重3.8g,收率65%,其结构鉴定数据同实施例1。Put 5g (11.8mmol) of compound II, 14.7mmol of compound IV and 2.36mmol of potassium hydroxide in a reaction flask, add 15ml of N,N-dimethylformamide (DMF), heat to 100°C, and react for 14 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 3.8g after drying, and the yield was 65%. The structural identification data was the same as in Example 1.
实施例15 制备化合物IExample 15 Preparation of Compound I
将5g(11.8mmol)化合物II、5.9mmol化合物IV和59mmol吡啶置于反应瓶中,加入500ml N,N-二甲基甲酰胺(DMF),加热至150℃,反应2小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重3.9g,收率66%,其结构鉴定数据同实施例1。Put 5g (11.8mmol) of compound II, 5.9mmol of compound IV and 59mmol of pyridine into a reaction flask, add 500ml of N,N-dimethylformamide (DMF), heat to 150°C, and react for 2 hours. After the reaction, add 100ml of water, stir at room temperature for 2 hours, separate out a large amount of solid, filter, wash the filter cake with water to obtain a white solid, weigh 3.9g after drying, yield 66%, its structural identification data is the same as in Example 1.
实施例16 制备化合物IExample 16 Preparation of Compound I
将5g(11.8mmol)化合物II、2.2g(13.3mmol)化合物IV和13.7mmol碳酸氢钠置于反应瓶中,加入100ml N,N-二甲基甲酰胺(DMF),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重4.4g,收率75%,其结构鉴定数据同实施例1。5g (11.8mmol) of compound II, 2.2g (13.3mmol) of compound IV and 13.7mmol of sodium bicarbonate were placed in a reaction flask, and 100ml of N,N-dimethylformamide (DMF) was added, heated to 130°C, and reacted 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 4.4g after drying, with a yield of 75%, and its structural identification data was the same as in Example 1.
实施例17 制备化合物IExample 17 Preparation of Compound I
将5g(11.8mmol)化合物III、2.2g(13.3mmol)化合物IV和13.7mmol碳酸钠置于反应瓶中,加入100ml N,N-二甲基甲酰胺(DMF),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重4.5g,收率78%,其结构鉴定数据同实施例1。5g (11.8mmol) of compound III, 2.2g (13.3mmol) of compound IV and 13.7mmol of sodium carbonate were placed in a reaction flask, and 100ml of N,N-dimethylformamide (DMF) was added, heated to 130°C, and reaction 4 Hour. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 4.5g after drying, with a yield of 78%, and its structural identification data was the same as in Example 1.
实施例18 制备化合物IExample 18 Preparation of Compound I
将5g(11.8mmol)化合物II、2.2g(13.3mmol)化合物IV和13.7mmol氢氧化锂置于反应瓶中,加入100ml N,N-二甲基甲酰胺(DMF),加热至130℃,反应4小时。反应结束后,加入100ml水,室温下搅拌2小时,析出大量固体,过滤,滤饼用水洗涤,得到白色固体,烘干后重4.5g,收率78%,其结构鉴定数据同实施例1。5g (11.8mmol) of compound II, 2.2g (13.3mmol) of compound IV and 13.7mmol of lithium hydroxide were placed in a reaction flask, and 100ml of N,N-dimethylformamide (DMF) was added, heated to 130°C, and reacted 4 hours. After the reaction was finished, add 100ml of water, stir at room temperature for 2 hours, a large amount of solids were separated out, filtered, and the filter cake was washed with water to obtain a white solid, which weighed 4.5g after drying, with a yield of 78%, and its structural identification data was the same as in Example 1.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110220005.1A CN102911169B (en) | 2011-08-02 | 2011-08-02 | Method for preparing lurasidone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110220005.1A CN102911169B (en) | 2011-08-02 | 2011-08-02 | Method for preparing lurasidone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102911169A CN102911169A (en) | 2013-02-06 |
| CN102911169B true CN102911169B (en) | 2015-05-06 |
Family
ID=47609771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110220005.1A Expired - Fee Related CN102911169B (en) | 2011-08-02 | 2011-08-02 | Method for preparing lurasidone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102911169B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014064714A2 (en) * | 2012-10-22 | 2014-05-01 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for preparation of lurasidone hydrochloride |
| ITMI20130262A1 (en) * | 2013-02-22 | 2014-08-23 | Edmond Pharma Srl | PROCEDURE FOR THE PREPARATION OF CHLORIDATED LURASIDONE |
| CZ306203B6 (en) * | 2013-12-06 | 2016-09-29 | Zentiva, K. S | Lurasidone synthesis process |
| CN106146486A (en) * | 2015-04-21 | 2016-11-23 | 上海医药集团股份有限公司 | A method for preparing lurasidone with high purity and high yield |
| CN109553614A (en) * | 2017-09-27 | 2019-04-02 | 北京万全德众医药生物技术有限公司 | The preparation of Lurasidone isomer impurities |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0464846A1 (en) * | 1990-07-06 | 1992-01-08 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives, and their production and use |
| CN101184489A (en) * | 2005-05-26 | 2008-05-21 | 大日本住友制药株式会社 | pharmaceutical composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4219696B2 (en) * | 2003-01-27 | 2009-02-04 | 大日本住友製薬株式会社 | Process for producing optically active trans-1,2-cyclohexanedicarboxylic acid derivative |
| JP4708012B2 (en) * | 2004-12-15 | 2011-06-22 | 大日本住友製薬株式会社 | Method for producing quaternary ammonium salt |
-
2011
- 2011-08-02 CN CN201110220005.1A patent/CN102911169B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0464846A1 (en) * | 1990-07-06 | 1992-01-08 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives, and their production and use |
| CN101184489A (en) * | 2005-05-26 | 2008-05-21 | 大日本住友制药株式会社 | pharmaceutical composition |
Non-Patent Citations (1)
| Title |
|---|
| 尚遂存.相转移催化技术简介.《有机化学实验操作与技术》.1996,(第1版),第16页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102911169A (en) | 2013-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102911169B (en) | Method for preparing lurasidone | |
| CN104829602A (en) | Brexpiprazole preparation method | |
| BR112015024255B1 (en) | Azoxystrobin preparation method | |
| CN102827156A (en) | Novel industrial synthetic method of dasatinib | |
| CN101691359A (en) | Method for synthesizing highly-pure bendamustine hydrochloride | |
| CN103304512A (en) | Preparation method for febuxostat | |
| CN105693691A (en) | New crystal form of high-purity trexagliptin and its preparation | |
| CN106256824B (en) | Preparation method of high-purity delafloxacin meglumine salt | |
| CN102796079B (en) | A kind of preparation method of methanesulfonic acid fluorine imatinib | |
| CN106749194A (en) | A kind of preparation method for a pyrimidine | |
| CN103664912B (en) | A kind of synthesis technique of prucalopride | |
| CN104402814A (en) | Method for synthesizing 2-chlorine-N-(2,4-difluorophenyl) nicotinamide by one-pot method | |
| CN103613562B (en) | A kind of preparation method of pramipexole | |
| CN102964343A (en) | N-acyl-4-tertiary butyl-5-(1, 2, 4-triazole-1-yl) thiazole-2-amine and preparation method and application thereof | |
| CN105541793A (en) | Synthetic method of trelagliptin, trelagliptin synthesized through method and trelagliptin synthesis intermediate | |
| CN104311493B (en) | The synthetic method of Fluoxastrobin | |
| CN104974105A (en) | Method of preparing 4-(4-aminophenyl)-3-morpholinone | |
| CN103224469A (en) | Pradaxa analogue with fluorine-containing group modified benzene ring as center and synthesis method thereof | |
| CN103319462B (en) | The preparation method of clopyrazosulfuron-methyl | |
| WO2022262548A1 (en) | Preparation method for compound fasudil hydrochloride | |
| CN103058950A (en) | Preparation method of febuxostat | |
| CN104230822A (en) | Method for synthesizing azoxystrobin | |
| CN101353347A (en) | A kind of preparation method of risperidone | |
| CN104496995A (en) | Method for preparing 3-ethynyl imidazo[1,2-b]pyridazine | |
| CN108383782A (en) | The synthetic method of 4- amidoquinaldines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150506 Termination date: 20200802 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |